Minireviews
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 7, 2016; 22(13): 3547-3557
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3547
Figure 1
Figure 1 Targeting liver cancer stem cells is necessary to prevent tumor recurrence. LCSCs are resistant to the current standard of care: surgical resection, radiotherapy and chemotherapy. Therapeutic approaches and strategies to target LCSCs in addition to the differentiated tumor cells are necessary to effectively treat the entire cancer and prevent tumor recurrence. LCSCs: Liver cancer stem cells.